Company
Every investor coverage indicates participated in a round Florey Institute raised.
Companies Florey Institute acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Gawain McColl | Associate Professor | Dealroom |
Stories naming Florey Institute. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
FeBI Technologies won an Australian government grant of about A$1.52 million for its quantum-based iron blood test, building on earlier Stage 1 funding, and will partner with universities and Aboriginal health services.
Brandon BioCatalyst's CUREator incubator has granted an extra $1.865m across four Australian biotechs working on antibiotic prescribing, schizophrenia, muscular dystrophy and autoimmune therapies, on top of their initial awards.
Startup Daily TV interviews Tessara Therapeutics' CEO about RealBrain, its 3D brain-tissue models for neurological drug discovery, and a fresh push to raise funds; the Melbourne biotech is also among the latest Tech23 companies.